NEW YORK, June 25, 2020 /PRNewswire/ — Espero BioPharma, Inc. is focused on the development of drugs for the treatment of cardiorenal diseases.  The company, a private Delaware corporation, is the result of a 2017 business combination between Espero Pharmaceuticals, Inc. and Armetheon, Inc. The company’s portfolio of products includes:  (i) tecarfarin, a Phase […]